Efficacy of ivabradine in heart rate reduction after cardiac transplantation: Systematic review and meta-analysis
Ivabradine reduces HR effectively in heart transplant recipients without added adverse outcomes, supporting its use as safe and well-tolerated alternative when conventional agents are unsuitable. Despite potential clinical benefit, small sample size and heterogeneity the need for larger randomized trials to confirm long-term outcomes and establish ivabradine's role in post-transplant care.
Authors
- Muhammad Abdullah Nizam (ORCID: https://orcid.org/0000-0003-1158-0728)
- Shayan Iqbal Khan (ORCID: https://orcid.org/0000-0003-2338-4759)
- Mushood Ahmed (ORCID: https://orcid.org/0000-0001-9872-8224)
- Madiha Kiyani
- Tehmasp Rehman Mirza (ORCID: https://orcid.org/0009-0002-8572-4579)
- Faseeh Haider
- Kanza Farhan
- Najam Gohar
- Zaima Afzaal
- Amro Taha
- Muhammad Usman
- Yasar Sattar
- Fawaz Alenezi
- Haider Hussain Shah
- Jesus Almendral
- Faizan Ahmed
- Kainat Jahangir
- Ramsha Ali
- Muhammad Fahad Khan Muhammad Fahad Khan
Institutions
- Duke University (US)
Publication Details
- Journal
- World Journal of Cardiology
- Published
- 2025-12-24
- DOI
- https://doi.org/10.4330/wjc.v17.i12.113820
- Primary Topic
- Heart rate and cardiovascular health
- Type
- article
- Field-Weighted Citation Impact
- 0.00